| Wall Street Journal. Europe 2006 John. Carreyrou |
| Title | Subject | Authors |
|---|
| Apotex launches generic Plavix, pressuring Bristol-Myers, Sanofi.(blood thinner medication)(pharmaceuticals)(includes Stock Quotes statistical table) | Business, international | John Carreyrou |
| Bristol-Myers's board fuels takeover rumors: Cornelius, who sold off the last firm he led, is picked as interim CEO.(James M. Cornelius)(Bristol-Myers Squibb Co.) | Business, international | Joann S. Lublin, John Carreyrou |
| Eli Lilly faces patent challenge from a long-ago collaboration.(pharmaceuticals)(medical research Gerald Crabtree)(includes Stock Quote and "Growth Script" statistical tables) | Business, international | John Carreyrou |
| How Bristol-Myers fumbled defense of $4 billion drug.(Bristol-Myers Squibb Co.)(Plavix)(includes Stock Quotes statistical table)(Company overview) | Business, international | Joann S. Lublin, John Carreyrou |
| Lilly sets deal to acquire Icos for about $2.1 billion.(Eli Lilly & Co.)(pharmaceuticals)(includes Stock Quotes statistical table) | Business, international | John Carreyrou |
| Merck, Schering-Plough results get boost from cholesterol drugs.(pharmaceuticals)(United States)(includes Stock Quotes and "Healthy Numbers" statistical tables)(Company overview) | Business, international | John Carreyrou, Greg Edwards |
| Merck's chief leads a revival, but will it last?(Richard T. Clark) | Business, international | John Carreyrou |
| Merck Vioxx probe clears officials; board-ordered report says management acted fairly, didn't intend to mislead. | Business, international | John Carreyrou, Heather Won Tesoriero |
| Michelin scion dies; Firm's reins leave family.(tires)(Edouard Michelin)(includes Stock Quote statistical table)(Company overview) | Business, international | John Carreyrou, Alessandra Galloni |
| Schering-Plough net leaps; Merck & Lilly notch gains.(pharmaceuticals)(United States)(includes Stock Quotes statistical table)(Industry overview)(Company overview) | Business, international | John Carreyrou |
| Wary of backlash, cancer-drug makers weigh price limits.(pharmaceuticals)(United States)(includes Stock Quotes statistical table)(Industry overview) | Business, international | John Carreyrou, Geeta Anand |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
